March Medical Group

March Medical Group's vision is to become a highly successful specialty pharmaceutical group developing and distributing products that address the needs and improve the quality of life of individual patients in all major international pharmaceutical markets.

March Medical Group in-licenses, reformulates, develops and distributes unlicensed medicines to address the special needs of individual patients. It also intends to market both authorised medicines and consumer healthcare products. It has a current focus on neurological and metabolic diseases. Palliative care, cosmo-ceuticals and food supplements are other areas of interest into which March Medical Group is planning to invest development efforts in the future.

Special Products Limited is March Medical's main subsidiary. Special Products supplies and is developing a pipeline of special medicinal products as well as candidates for the regulatory approval process.

We work closely with expert healthcare practitioners and seek to serve the needs of the patient as our highest priority. We aim to operate to high ethical, regulatory and professional standards and to provide our staff with appropriate training and development to ensure we meet the needs of patients.